1,886
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Regulation of P-glycoprotein by Bajijiasu in vitro and in vivo by activating the Nrf2-mediated signalling pathway

, , , , , , & show all
Pages 184-192 | Received 03 Jul 2018, Accepted 21 Jan 2019, Published online: 30 Mar 2019

References

  • Allen JD, van Loevezijn A, Lakhai JM, van der Valk M, van Tellingen O, Reid G, Schellens JH, Koomen GJ, Schinkel AH. 2002. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther. 1:417–425.
  • Borrelli F, Izzo AA. 2009. Herb–drug interactions with St John’s wort (Hypericum perforatum): an update on clinical observations. AAPS J. 11:710–727.
  • Cai H, Wang Y, He J, Cai T, Wu J, Fang J, Zhang R, Guo Z, Guan L, Zhan Q, et al. 2017. Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice. Oncotarget. 8:92621–92634.
  • Chen DL, Zhang P, Lin L, Zhang HM, Deng SD, Wu ZQ, Ou S, Liu SH, Wang JY. 2014. Protective effects of bajijiasu in a rat model of Aβ25-35-induced neurotoxicity. J Ethnopharmacol. 154:206–217.
  • Eckford PD, Sharom FJ. 2009. ABC efflux pump-based resistance to chemotherapy drugs. Chem Rev. 109:2989–3011.
  • Giacomini KM, Huang S-M, Tweedie DJ, Benet LZ, Brouwer KLR, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, et al. 2010. Membrane transporters in drug development. Nature Reviews. Drug Discov. 9:215–236.
  • He JL, Zhou ZW, Yin JJ, He CQ, Zhou SF, Yang Y. 2014. Schisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathway. Drug Des Dev Ther. 2015:127–146.
  • Hong G, Zhou L, Shi X, He W, Wang H, Wei Q, Chen P, Qi L, Tickner J, Lin L, et al. 2017. Bajijiasu abrogates osteoclast differentiation via the suppression of RANKL signaling pathways through NF-kappaB and NFAT. Int J Mol Sci. 18:1–12.
  • Hou Z, Chen L, Fang P, Cai H, Tang H, Peng Y, Deng Y, Cao L, Li H, Zhang B, et al. 2018. Mechanisms of triptolide-induced hepatotoxicity and protective effect of combined use of isoliquiritigenin: possible roles of Nrf2 and hepatic transporters. Front Pharmacol. 9:1–15.
  • Hu T, To KK, Wang L, Zhang L, Lu L, Shen J, Chan RL, Li M, Yeung JH, Cho CH. 2014. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Phytomedicine: Int J Phytother Phytopharmacol. 21:1264–1272.
  • Izzo AA, Ernst E. 2009. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 69:1777–1798.
  • Klaassen CD, Aleksunes LM. 2010. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev. 62:1–96.
  • Lee YK, Bang HJ, Oh JB, Whang WK. 2017. Bioassay-guided isolated compounds from Morinda officinalis inhibit Alzheimer’s disease pathologies. Molecules. 22:1–12.
  • Li N, Qin LP, Han T, Wu YB, Zhang QY, Zhang H. 2009. Inhibitory effects of Morinda officinalis extract on bone loss in ovariectomized rats. Molecules (Basel, Switzerland). 14:2049–2061.
  • Liang J, Liang J, Hao H, Lin H, Wang P, Wu Y, Jiang X, Fu C, Li Q, Ding P, et al. 2017. The extracts of Morinda officinalis and its hairy roots attenuate dextran sodium sulfate-induced chronic ulcerative colitis in mice by regulating inflammation and lymphocyte apoptosis. Front Immunol. 8:905.
  • Ma Q. 2013. Role of Nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 53:401–426.
  • Rigalli JP, Ruiz ML, Perdomo VG, Villanueva SS, Mottino AD, Catania VA. 2011. Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells. Toxicology. 285:18–24.
  • Seo JY, Lee YS, Kim HJ, Lim SS, Lim JS, Lee IA, Lee CH, Yoon Park JH, Kim JS. 2010. Dehydroglyasperin C isolated from licorice caused Nrf2-mediated induction of detoxifying enzymes. J Agric Food Chem. 58:1603–1608.
  • Shen G, Kong AN. 2009. Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm & Drug Dispos. 30:345–355.
  • Shi J, Cui N, Jia TZ. 2015. Effect of different processed products and extracts of Morinda officinalis root on adjuvant-induced arthritis in rats. Zhong Yao Cai. 38:1626–1629.
  • Song B, Wang F, Wang W. 2015. Effect of aqueous extract from Morinda officinalis F. C. How on microwave-induced hypothalamic-pituitary-testis axis impairment in male Sprague–Dawley rats. Evid Based Complement Alternat Med. 2015:360730.
  • Verschraagen M, Koks CH, Schellens JH, Beijnen JH. 1999. P-Glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil. Pharmacol Res. 40:301–306.
  • Wu J, Cheng Z, Zhu L, Lu L, Zhang G, Wang Y, Xu Y, Lin N, Liu Z. 2014. Coadministration of Pinellia ternata can significantly reduce Aconitum carmichaelii to inhibit CYP3A activity in rats. Evid Based Complement Alternat Med. 2014:734867.
  • Wu J, Lin N, Li F, Zhang G, He S, Zhu Y, Ou R, Li N, Liu S, Feng L, et al. 2016. Induction of P-glycoprotein expression and activity by Aconitum alkaloids: implication for clinical drug-drug interactions. Sci Rep. 6:25343.
  • Zhang JH, Xin HL, Xu YM, Shen Y, He YQ, Hsien Y, Lin B, Song HT, Juan L, Yang HY, et al. 2018. Morinda officinalis How. – a comprehensive review of traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 213: 230–255.
  • Zhou SF. 2008. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 38:802–832.